OmniSYS acquires voiceTech, Fusion-Rx platform

Press enter to search
Close search
Open Menu

OmniSYS acquires voiceTech, Fusion-Rx platform

By David Salazar - 03/17/2017

DALLAS — Medical claims billing, Medicare compliance and pharmacy patient engagement solutions company OmniSYS recently added to its suite of pharmacy solutions. The company acquired voiceTech, bringing the Fusion-Rx platform into the company’s fold.

“In keeping with our mission to improve the health of healthcare, we are always looking for ways to expand our portfolio in order to deliver added value to our pharmacy customers and the patients they serve,” OmniSYS CEO John King said. “That is why we are excited to announce our recent acquisition of voiceTech and its Fusion-Rx platform.”

Fusion-Rx is a patient adherence and communication tool that integrates inbound IVR and Star rating outbound messaging, bringing 24/7 pharmacy access over the phone, online and on mobile devices, the company said.

“This new technology complements our existing solutions — CareCLAIM, OmniLINK, and Analytix — and enhances our patient engagement capabilities,” King said.  “It also features cloud-based API connectivity to over 60 pharmacy management systems, enabling us to access an expanded dataset, including prescription data that will lead to new engagement opportunities and enhanced business insight.”

As a result of the acquisition, OmniSYS will expand its office locations to include a second operations center in Sarasota, Fla. The company currently has an existing operations center in Greenville, Texas, and corporate headquarters in Dallas. To ensure a seamless transition and the integration of Fusion-Rx into the OmniSYS portfolio, the company said key voiceTech executives would remain with the company.

“We are proud to become part of the OmniSYS family,” voiceTech co-founder and president Tim Garofalo said. “Our companies have similar values and a shared commitment to the industry. With a focus on expanding patient engagement, our blended solution offers promising opportunities for both pharmacies and our company.”